Preparation and in vitro biological evaluation of tetrapyrrole ethanolamide derivatives as potential anticancer agents

Bioorganic and Medicinal Chemistry Letters

Volumn 18, Issue 1, 2008, Pages 360-365

  Girard, Denis ^a   Weagle, Glenn ^a   Gupta, Atul ^a   Bérubé, Gervais ^a   Chapados, Camille ^a  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

Author keywords

Hematoporphyrin; Hematoporphyrin propylether ethanolamide; Pheophorbide ethanolamide; Photodynamic therapy

Indexed keywords

AMIDE; DOXORUBICIN; ETHANOLAMIDE DERIVATIVE; HEMATOPORPHYRIN; HEMATOPORPHYRIN PROPYLETHER ETHANOLAMINE; METHYLPHEOPHORBIDE; PHEOPHORBIDE; PHEOPHORBIDE A ETHANOLAMIDE; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL STRAIN K 562; CELL SURVIVAL; CONTROLLED STUDY; CULTURE MEDIUM; DAUDI CELL; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE; EVALUATION; HELA CELL; HEMOLYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; PHOTODYNAMICS; RAJI CELL; REACTION ANALYSIS; STRUCTURE ANALYSIS;

ALKYLATION; AMIDES; ANTINEOPLASTIC AGENTS; ERYTHROCYTES; ETHANOL; HELA CELLS; HEMATOPORPHYRINS; HEMOLYSIS; HUMANS; PHOTOSENSITIZING AGENTS; TETRAPYRROLES;

EID: 37549013761     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.10.069     Document Type: Article

References (19)

1. Pandey R.K. J. Porphyrins Phthalocyanines 4 (2000) 368
2. Silva J.N., Filipe P., Morliere P., Maziere J.C., Freitas J.P., Cirne De Castro J.L., and Santus R. Bio-Med. Mater. Eng. 16 (2006) S147
3. MacDonald I.J., and Dougherty T.J. J. Porphyrins Phthalocyanines 5 (2001) 105
4. Li L., Luo R., Liao W., Zhang M., Luo Y., and Miao J. Photo. Photodyn. Ther. 3 (2006) 266
5. Maugain E., Sasnouski S., Zorin V., Merlin J., Guillemin F., and Bezdetnaya L. Oncol. Rep. 12 (2004) 639
6. Goldenberg G.J., and Moore M.J. Cancer Ther. (1997) 3
7. Garban Z., Roth L., Ion N., Marculescu E., Brazda M., Siniteanu A., Muresan C., and Neda G. Timisoara Medicala 31 (1986) 71
8. Calabresi, P.; Chabner, B. A. Chemotherapy of Neoplastic Diseases. In Gilman, A. G., Rall, T.W., Nies, A.S., Taylor, P., Eds.; 1990; pp 1202-1219.
9. Calsou P., and Salles B. Cancer Chemother. Pharm. 32 (1993) 85
10. Marnett, L. J.; Kozak, K. R. PCT Int. Appl., 2002, WO 2002012445, 62 pp.
11. De Petrocellis L., Bisogno T., Ligresti A., Bifulco M., Melck D., and Di Marzo V. Fund. Clin. Pharm. 16 4 (2002) 297
12. Grimaldi C., and Bifulco M. Pharm. (online) (2007) 1
13. Contassot E., Tenan M., Schnuriger V., Pelte M.F., and Dietrich P.Y. Gyneco. Oncol. 93 1 (2004) 182
14. Belykh D.V., Karmanova L.P., Spirikhin L.V., and Kutchin A.V. Mendeleev Commun. 2 (2002) 77
15. Kuchin A.V., Ol'shevskaya V.A., Mal'shakova M.V., Belykh D.V., Petrovskii P.V., Ivanov O.G., Shtil' A.A., and Kalinin V.N. Doklady Chem. 409 2 (2006) 135
16. Cole S.P.C. Cancer Chemother. Pharm. 17 (1986) 259
17. Carmichael J., DeGrapp W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Cancer Res. 47 (1987) 943
18. Ford C.H.J., Richardson V.J., and Tsaltas G. Cancer Chemother. Pharm. 24 (1989) 295
19. 6; C, 68.72; H, 7.86; N, 10.93. Found: C, 68.52; H, 8.03; N, 10.79.Photosensitization activity measured by photohemolysis: Photohemolysis involves the measurement of hemoglobin released from damaged red blood cells by absorption spectroscopy. The red blood cell damage is a result of photosensitization by the drug. The red blood cells and photosensitization drug are combined in the presence of light for a specified light dose. After 24 h in the dark the amount of hemoglobin released from the damaged cells was measured. Human whole blood (0.75 mL) was washed three times in TBS.